nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.0883	0.127	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.0883	0.127	CbGpPWpGaD
Bromodiphenhydramine—Mepyramine—SLC22A4—ulcerative colitis	0.0775	0.254	CrCbGaD
Bromodiphenhydramine—Mepyramine—SLC22A5—ulcerative colitis	0.0583	0.191	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.045	0.0647	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.045	0.0647	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.0347	0.0499	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.028	0.0403	CbGpPWpGaD
Bromodiphenhydramine—Fenoprofen—PTGS1—ulcerative colitis	0.0266	0.0872	CrCbGaD
Bromodiphenhydramine—Imipramine—SLC22A4—ulcerative colitis	0.0214	0.07	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—SLC22A5—ulcerative colitis	0.0213	0.0697	CrCbGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.0204	0.0294	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.0204	0.0294	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.0177	0.0254	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.0177	0.0254	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.0176	0.0253	CbGpPWpGaD
Bromodiphenhydramine—Fenoprofen—PTGS2—ulcerative colitis	0.0152	0.0498	CrCbGaD
Bromodiphenhydramine—Toremifene—ABCB1—ulcerative colitis	0.0137	0.045	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.0136	0.0196	CbGpPWpGaD
Bromodiphenhydramine—Fenoprofen—ALB—ulcerative colitis	0.0135	0.0444	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.0131	0.0188	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.0127	0.0183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—ADRB2—ulcerative colitis	0.0119	0.0172	CbGpPWpGaD
Bromodiphenhydramine—Diphenhydramine—PTGS1—ulcerative colitis	0.0116	0.0379	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ALB—ulcerative colitis	0.0114	0.0372	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.011	0.0158	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—ABCB1—ulcerative colitis	0.0108	0.0355	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.0104	0.0149	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.0104	0.0149	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.01	0.0144	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00803	0.0116	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00803	0.0116	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.00693	0.00997	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.00647	0.0093	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCB1—ulcerative colitis	0.00548	0.018	CrCbGaD
Bromodiphenhydramine—Doxepin—ABCB1—ulcerative colitis	0.00546	0.0179	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.005	0.0072	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00469	0.00674	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.00458	0.00659	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ALB—ulcerative colitis	0.00443	0.0145	CrCbGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—JAK2—ulcerative colitis	0.00425	0.00612	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—ABCB1—ulcerative colitis	0.00425	0.0139	CrCbGaD
Bromodiphenhydramine—Amitriptyline—ABCB1—ulcerative colitis	0.00422	0.0138	CrCbGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—RELA—ulcerative colitis	0.00412	0.00593	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00408	0.00587	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00408	0.00587	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00401	0.00578	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00372	0.00535	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00367	0.00528	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.0036	0.00517	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00352	0.00507	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—NFKB1—ulcerative colitis	0.00347	0.005	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.00347	0.005	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00345	0.00496	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00322	0.00463	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00314	0.00452	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—STAT3—ulcerative colitis	0.00312	0.00449	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00306	0.0044	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00304	0.00437	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00295	0.00425	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL20—ulcerative colitis	0.00268	0.00386	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.0026	0.00374	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.00254	0.00366	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00239	0.00344	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00238	0.00343	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.00233	0.00335	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.0023	0.00331	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCR6—ulcerative colitis	0.00225	0.00324	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00198	0.00285	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00197	0.00284	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GHRL—ulcerative colitis	0.00181	0.00261	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.0018	0.00259	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00173	0.00249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00157	0.00226	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00152	0.00218	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRB2—ulcerative colitis	0.0015	0.00216	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00146	0.00211	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00143	0.00205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00141	0.00203	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL20—ulcerative colitis	0.00138	0.00198	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.00137	0.00196	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00135	0.00195	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GNA12—ulcerative colitis	0.0013	0.00186	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00127	0.00183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00123	0.00177	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR6—ulcerative colitis	0.00115	0.00166	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SEL1L—ulcerative colitis	0.00113	0.00162	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00112	0.00161	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00102	0.00147	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00102	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000952	0.00137	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GHRL—ulcerative colitis	0.00093	0.00134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCR1—ulcerative colitis	0.000927	0.00133	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000915	0.00132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CALM3—ulcerative colitis	0.000901	0.0013	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000848	0.00122	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL20—ulcerative colitis	0.000814	0.00117	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRB2—ulcerative colitis	0.00077	0.00111	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GNA12—ulcerative colitis	0.000765	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCR2—ulcerative colitis	0.000725	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000725	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000722	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00072	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR6—ulcerative colitis	0.000682	0.000981	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000654	0.000941	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAML2—ulcerative colitis	0.000646	0.00093	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTGER4—ulcerative colitis	0.0006	0.000864	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GHRL—ulcerative colitis	0.00055	0.000791	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CALM3—ulcerative colitis	0.000532	0.000766	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RIPK2—ulcerative colitis	0.000524	0.000755	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRB2—ulcerative colitis	0.000455	0.000655	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000449	0.000646	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.00041	0.000589	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—JAK2—ulcerative colitis	0.000408	0.000586	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—IL2—ulcerative colitis	0.000391	0.000563	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADCY5—ulcerative colitis	0.000386	0.000556	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000372	0.000535	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL2—ulcerative colitis	0.000356	0.000512	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JAK2—ulcerative colitis	0.000241	0.000346	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RELA—ulcerative colitis	0.000233	0.000336	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	0.00022	0.000316	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL2—ulcerative colitis	0.00021	0.000302	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6—ulcerative colitis	0.000209	0.000301	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP9—ulcerative colitis	0.000199	0.000286	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	0.000197	0.000283	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STAT3—ulcerative colitis	0.000177	0.000254	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	0.000164	0.000236	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TP53—ulcerative colitis	0.000135	0.000194	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6—ulcerative colitis	0.000123	0.000178	CbGpPWpGaD
